Both in Biotechnology
Halozyme Therapeutics vs Vaxcyte
Over the past year HALO returned +94.3% and PCVX returned +42.0%; their daily moves had a correlation of 0.13.
HALO +94.3% PCVX +42.0%Growth of $1, one year, split-adjusted
| Metric | HALO | PCVX |
|---|---|---|
| Price | $128.62 | $60.81 |
| Market cap | $14.60B | $9.57B |
| Today | −0.26% | +0.31% |
| 1 month | +18.8% | −17.6% |
| 6 months | +95.3% | +9.3% |
| Year to date | +91.1% | +31.8% |
| 1 year | +97.3% | +34.3% |
| Revenue growth (YoY) | +47.7% | — |
| Gross margin | 83.5% | — |
| Net margin | 47.8% | — |
| P/E (TTM) | 35.3× | — |
| Price / sales | 8.8× | — |
| Net cash | -$1.92B | $1.49B |
| Dividend yield | — | — |
| Volatility (60d) | 27.8% | 70.6% |
| Short % of float | 12.4% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).